SCHEMBL1883475

SCHEMBL1883475

CC=Cc1ccccc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 5/20 0.64
TRPA1 O75762 1/20 0.64
TFEB P19484 1/20 0.60
CYP1A1 P04798 3/20 0.58
CYP1A2 P05177 3/20 0.58
CYP1B1 Q16678 3/20 0.58
KDM4E B2RXH2 2/20 0.58
CYP19A1 P11511 1/20 0.56
CYP3A4 P08684 2/20 0.54
HMGCR P04035 1/20 0.54
NPC1 O15118 2/20 0.53
MAPT P10636 2/20 0.53
RAB9A P51151 2/20 0.53
LMNA P02545 1/20 0.53
BCHE P06276 1/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA4 P22748 1/20 0.52
CA7 P43166 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1883472 1.00 NFE2L2 (0.64) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL4461398 1.00 NFE2L2 (0.64) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL29580852 1.00 NFE2L2 (0.64) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL7915752 0.88 NFE2L2 (0.79) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL1603719 0.88 NFE2L2 (0.79) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL4019329 0.88 NFE2L2 (0.79) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL3669785 0.84 NFE2L2 (0.45) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL21110871 0.84 NFE2L2 (0.45) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL6158840 0.83 NFE2L2 (0.55) NFE2L2TRPA1TFEBCYP1A1CYP1A2
SCHEMBL16933894 0.82 NFE2L2 (0.64) NFE2L2TRPA1TFEBCYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455937-B1 CHELATING CARBENE LIGAND PRECURSORS AND THEIR USE IN THE SYNTHESIS OF METATHESIS CATALYSTS MATERIA INC (US) 2018-04-11 EP claimed
CN-105692770-B The device and its method of work of inorganic non-metallic pollutant in a kind of semi-automatic formula processing waste water that reloads 徐州工程学院 2018-01-19 CN claimed
US-7268242-B2 Contacting a metathesis-active metal carbene complex with an internal olefin ligand precursors followed by crystallization from an organic solvent MATERIA, INC. (US) 2007-09-11 US claimed
US-7026495-B1 Using beta-substituted styrenes instead of terminal olefin compounds such as unsubstituted styrenes to react with a ruthenium complex;recovered and reused; oxidation resistance; storage stability; efficiency; polymerization; cuprous chloride-free and nontoxic; materials handling MATERIA, INC. (US) 2006-04-11 US claimed
US-20040014764-A1 N-myristoyltransferase inhibitor compositions and methods of use SMITH CHARLES D (US) 2004-01-22 US claimed
US-20260078089-A1 BIOACTIVE PHYTOCHEMICALS IN ZIZYPHUS AND GUARANA PHYTOQUEST LIMITED (GB) 2026-03-19 US disclosed
CN-114315563-B Process for producing branched carboxylic acid compound 常州大学 2023-12-08 CN disclosed
CN-114539129-B Allylamine bifunctional compound and application thereof 上海中医药大学附属龙华医院 2023-06-09 CN disclosed
US-20210403424-A1 BIOACTIVE PHYTOCHEMICALS IN ZIZYPHUS AND GUARANA PHYTOQUEST LTD (GB) 2021-12-30 US disclosed
EP-3890729-A1 BIOACTIVE PHYTOCHEMICALS IN ZIZYPHUS AND GUARANA Phytoquest Limited (GB) 2021-10-13 EP disclosed
EP-3814569-A1 TEXTILE INKJET PRINTING INK International Imaging Materials Inc. (US) 2021-05-05 EP disclosed
WO-2020115475-A1 BIOACTIVE PHYTOCHEMICALS IN ZIZYPHUS AND GUARANA PHYTOQUEST LIMITED (GB) 2020-06-11 WO disclosed
US-4967009-A REACTING UNSATURATED AROMATIC COMPOUNDS WITH AROMATIC IODOSYL COMPOUNDS TO YIELD AROMATIC ALDEHYDES OR KETONES NIPPON PETROCHEMICALS CO., LTD. (JP) 1990-10-30 US disclosed
EP-0350069-A2 Method for oxidizing unsaturated aromatic compounds NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) 1990-01-10 EP disclosed
EP-0104863-B1 LIGHT-SENSITIVE PLANOGRAPHIC PRINTING PLATE FUJI PHOTO FILM CO., LTD. (JP) 1989-05-03 EP disclosed
EP-0067105-B1 ALLYL AMINE MAO INHIBITORS MERRELL DOW FRANCE ET CIE (FR) 1987-09-23 EP disclosed
EP-0180771-A1 Method for improving impulse breakdown strength of electrically insulating materials Nippon Petrochemicals Co., Ltd. (JP) 1986-05-14 EP disclosed
US-4454158-A Allyl amine MAO inhibitors MERRELL TORAUDE ET COMPAGNIE (FR) 1984-06-12 US disclosed
EP-0067105-A2 Allyl amine MAO inhibitors MERRELL DOW FRANCE ET CIE (FR) 1982-12-15 EP disclosed
US-4085165-A ISOCYANATE PREPOLYMER, VINYL COMPOUND, POLYAMINE OR POLYETHER CURING AGENT BRIDGESTONE TIRE CO., LTD. (JA) 1978-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078089-A1 BIOACTIVE PHYTOCHEMICALS IN ZIZYPHUS AND GUARANA CHIT1, MAN2A1, DPP9 NFE2L2 1668/4885TRPA1 1248/4885TFEB 1874/4885
US-20210403424-A1 BIOACTIVE PHYTOCHEMICALS IN ZIZYPHUS AND GUARANA PRAP1, PEPD, PPIA NFE2L2 858/4885TRPA1 3059/4885TFEB 3247/4885
US-20040014764-A1 N-myristoyltransferase inhibitor compositions and methods of use NMT2, NMT1, MBOAT1 NFE2L2 2774/4885TRPA1 4207/4885TFEB 2275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.